A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy

BACKGROUND: It is extremely difficult to develop targeted treatments for triple-negative breast (TNB) cancer, because these cells do not express any of the key biomarkers usually exploited for this goal. RESULTS: In this work, we develop a solution in the form of a cascade responsive nanoplatform ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Shiwei, Williams, Gareth R., Wu, Jianrong, Wu, Junzi, Zhang, Xuejing, Chen, Xia, Li, Shude, Jiao, Jianlin, Zhu, Li-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737697/
https://www.ncbi.nlm.nih.gov/pubmed/31506085
http://dx.doi.org/10.1186/s12951-019-0529-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737697/
https://www.ncbi.nlm.nih.gov/pubmed/31506085
http://dx.doi.org/10.1186/s12951-019-0529-4

Ejemplares similares